Michael Lowings

发表

Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.

D. Mannino, N. Leidy, B. Miller, 2016, American journal of respiratory and critical care medicine.

COPD_A_309320 1637..1646

W. Fahy, S. West, W. Meeraus, 2021 .

Epigenetic bystander-like effects of stroke in somatic organs

B. Kolb, A. Muhammad, O. Kovalchuk, 2012, Aging.

Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD.

D. Mannino, N. Leidy, J. Vestbo, 2024, Chronic obstructive pulmonary diseases.